Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Brain Sciences|June 27, 2024
Gut Microbiota and Gastrointestinal Symptoms in the Global Assessment of Obsessive-Compulsive Disorder: A Narrative Review of Current Evidence and Practical ImplicationsGiacomo Grassi, Ilenia Pampaloni
The British Journal of Psychiatry : the Journal of Mental Science|February 16, 2026
Obsessive-compulsive disorder (OCD): often a missed diagnosis and misdiagnosedVlasios Brakoulias, Ilenia Pampaloni, Naomi A Fineberg
The Australian and New Zealand Journal of Psychiatry|November 6, 2012
Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyondNaomi A Fineberg, Samar Reghunandanan, Angus Brown, et al.
The International Journal of Neuropsychopharmacology|January 10, 2012
Evidence-based pharmacotherapy of obsessive-compulsive disorderNaomi A Fineberg, Angus Brown, Samar Reghunandanan, et al.
International Clinical Psychopharmacology|October 6, 2007
Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorderNaomi A Fineberg, Ilenia Pampaloni, Stefano Pallanti, et al.
Journal of Neurology|March 31, 2010
Motor cortex excitability correlates with novelty seeking in social anxiety: a transcranial magnetic stimulation investigationStefano Pallanti, Alessandra Borgheresi, Ilenia Pampaloni, et al.
Comprehensive Psychiatry|August 25, 2022
The global assessment of OCDIlenia Pampaloni, Sabina Marriott, Enrico Pessina, et al.
Comprehensive Psychiatry|August 27, 2024
Clarifying the prevalence of OCD: A response to reader commentsIlenia Pampaloni, Lucy Morris, Himanshu Tyagi, et al.
Comprehensive Psychiatry|March 26, 2026
Inpatient hospital admissions for people with obsessive-compulsive disorder (OCD). A position statement by the international college of obsessive-compulsive spectrum disordersVlasios Brakoulias, Umberto Albert, Samuel R Chamberlain, et al.
International Clinical Psychopharmacology|August 17, 2018
Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorderNaomi A Fineberg, David S Baldwin, Lynne M Drummond, et al.
Pageof 2